_1777352244987_250242181.png&w=48&q=75){kind=small}
Drug Authority Alerts on Fake Tajreso 80 mg
The Drug Authority issued a warning regarding counterfeit packages of the medication "Tagrisso 80 mg" used for lung cancer treatment, after AstraZeneca confirmed that the circulating packages are neither theirs nor produced by them. The Authority called on pharmacists and citizens not to use the suspected product and to verify its source. It also requested the seizure and proper storage of all non-compliant packages, especially those bearing the batch number FEST, with manufacturing date 06/2025 and expiration date 05/2028, in order to protect patients' health.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)